Clinical trial Recruiting at 1 site Interventional Ages 21 and up

See if exposure to anti-smoking messages encourages menthol cigarette quit attempts

Official title: The DoubleTake Study: A Randomized, Waitlist-Controlled Trial of Message Exposure Delivered Via a Discrete Choice Experiment With Eye-Tracking on Quit Attempts Among Adults Who Smoke Menthol Cigarettes

Run by Georgia State University · NCT07782879 · Data updated 2026-11-12

This study tests whether viewing anti-smoking messages in a picture-heavy choice task with eye-tracking helps adults who smoke menthol cigarettes to try to quit.

More E-cigarette Use trials

Quick facts

Study typeInterventional
Ages21 Years and up
SexAll
Enrollment200 (estimated)
SponsorGeorgia State University
Academic / other
Locations2 sites (Santa Barbara, California and 1 other locations)
StatusRecruiting
StartedSeptember 21, 2026
Main results expectedAugust 2027
Study endsAugust 2027
Registry record updatedSeptember 25, 2026
Trial IDNCT07782879 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults age 21+ who smoke menthol cigarettes at least weekly in the past 30 days and can participate in an in-person study (English-speaking; no eye conditions affecting tracking).

Probably not a fit

Individuals unable to quit or who do not report a quit attempt in the follow-up period may not experience a direct benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, waitlist-controlled study investigates whether exposure to multiple anti-smoking messages during a discrete choice experiment with eye-tracking influences quitting-related behaviors in adults who smoke menthol cigarettes. Participants are 21 or older, smoke menthol cigarettes at least weekly, and can participate in person. The primary outcome is whether a quit attempt is reported in the two weeks after randomization. The trial compares immediate exposure to messages versus a two-week delay, to understand downstream behavioral impact beyond message preferences. Approximately 200 participants are planned, enrolled at sites in Santa Barbara, CA and Atlanta, GA, with collaboration from UCSB and NCI.

Why it matters

Potential benefit: If successful, this approach could inform public health messaging strategies that more effectively prompt quit attempts among menthol cigarette users.

How similar studies have gone: Prior work shows messaging features influence preferences, but this study tests a downstream behavioral effect of exposure in a controlled setting with eye-tracking, which is relatively novel for this outcome.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 21+ years
* Smoked menthol cigarettes at least once a week in the past 30 days
* Can speak, read, and write in English
* Willing to participate in an in-person study

Exclusion Criteria:

* Eye conditions affecting fixation, ocular motility, or central acuity (e.g., strabismus, nystagmus, ptosis, aniridia, maculopathy, advanced cataracts, or other conditions affecting macular fixation or central visual acuity).
* Multifocal or near-infrared-blocking/heavily tinted corrective lenses: bifocal, trifocal, or progressive/varifocal lenses, or coatings that impair eye-tracking. (Single-vision glasses and contact lenses are eligible.)

Where it's running

  • Georgia State University
    Atlanta, Georgia, United States
    Recruiting
  • University of California, Santa Barbara
    Santa Barbara, California, United States
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.